Potential miRNA-gene interactions determining progression of various ATLL cancer subtypes after infection by HTLV-1 oncovirus

Potential miRNA-gene interactions determining progression of various ATLL cancer subtypes after infection by HTLV-1 oncovirus

Abstract Background Adult T-cell Leukemia/Lymphoma (ATLL) is a rapidly progressing type of T-cell non-Hodgkin lymphoma that is developed after the infection by human T-cell leukemia virus type 1 (HTLV-1). It could be categorized into four major subtypes, acute, lymphoma, chronic, and smoldering. The...

Full description

Bibliographic Details
Main Authors:	Mohadeseh Zarei Ghobadi, Elaheh Afsaneh, Rahman Emamzadeh, Mona Soroush
Format:	Article
Language:	English
Published:	BMC 2023-03-01
Series:	BMC Medical Genomics
Subjects:	Asymptomatic carriers ATLL subtypes HTLV-1 Interaction WGCNA
Online Access:	https://doi.org/10.1186/s12920-023-01492-0

Similar Items

Exploration of mRNAs and miRNA classifiers for various ATLL cancer subtypes using machine learning
by: Mohadeseh Zarei Ghobadi, et al.
Published: (2022-04-01)

Decoding pathogenesis factors involved in the progression of ATLL or HAM/TSP after infection by HTLV-1 through a systems virology study
by: Mohadeseh Zarei Ghobadi, et al.
Published: (2021-08-01)

A Preclinical Model for the ATLL Lymphoma Subtype With Insights Into the Role of Microenvironment in HTLV-1-Mediated Lymphomagenesis
by: Mattia Vicario, et al.
Published: (2018-06-01)

HTLV-1, ATLL, severe hypercalcaemia and HIV-1 co-infection: an overview
by: Abdullah Ebrahim Laher, et al.
Published: (2018-05-01)

Leukemia / Lymphoma T of the adult HTLV1, a challenge for the clinic
by: María Elena Cabrera, et al.
Published: (2020-03-01)

Targeting HTLV-1 Activation of NFκB in Mouse Models and ATLL Patients
by: Lee Ratner, et al.
Published: (2011-06-01)

Blockade of LIRs as a new approach for diagnostics and treatment of ATLL malignancy
by: M. Keikha, et al.
Published: (2022-01-01)

Identification of novel miRNAs potentially involved in the pathogenesis of adult T-cell leukemia/lymphoma using WGCNA followed by RT-qPCR test of hub genes
by: Ali Shayeghpour, et al.
Published: (2023-02-01)

Adult T-cell leukemia-lymphoma in a patient with HTLV-I/II associated myelopathy Leucemia - linfoma de células T do adulto em um paciente com mielopatia associada a HTLV-I/II
by: Virgínia Freitas, et al.
Published: (1997-06-01)

Mechanisms of Oncogenesis by HTLV-1 Tax
by: Suchitra Mohanty, et al.
Published: (2020-07-01)

Cytokine Networks Dysregulation during HTLV-1 Infection and Associated Diseases
by: Nicolas Futsch, et al.
Published: (2018-12-01)

Lesões dermatológicas em pacientes infectados pelo vírus linfotrópico humano de células T do tipo 1 (HTLV-1) Dermatologic lesions in patients infected with the human T-cell lymphotropic vírus type 1 (HTLV-1)
by: Vandack Nobre, et al.
Published: (2005-02-01)

Latency Reversing Agents: Kick and Kill of HTLV-1?
by: Annika P. Schnell, et al.
Published: (2021-05-01)

Overview on coinfection of HTLV-1 and tuberculosis: Mini-review
by: Masoud Keikha, et al.
Published: (2021-05-01)

A transgenic mouse model of human T-cell leukemia virus type I (HTLV-1)–associated diseases
by: Takeo eOhsugi
Published: (2013-03-01)

Small RNA Profiling in an HTLV-1-Infected Patient with Acute Adult T-Cell Leukemia-Lymphoma at Diagnosis and after Maintenance Therapy: A Case Study
by: Rodrigo Pessôa, et al.
Published: (2023-06-01)

Mechanisms Involved in the Promoting Activity of Fibroblasts in HTLV-1-Mediated Lymphomagenesis: Insights into the Plasticity of Lymphomatous Cells
by: Giulia Rigotto, et al.
Published: (2021-09-01)

Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals
by: Enose-Akahata Yoshimi, et al.
Published: (2013-02-01)

Mechanisms of Innate Immune Sensing of HTLV-1 and Viral Immune Evasion
by: Suchitra Mohanty, et al.
Published: (2023-05-01)

HTLV-1-Mediated Epigenetic Pathway to Adult T-Cell Leukemia–Lymphoma
by: Makoto Yamagishi, et al.
Published: (2018-07-01)

HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina
by: Paula Benencio, et al.
Published: (2020-09-01)

Early Effects of HTLV-1 Infection on the Activation, Exhaustion, and Differentiation of T-Cells in Humanized NSG Mice
by: Otávio de Melo Espíndola, et al.
Published: (2021-09-01)

HTLV-1, the Other Pathogenic Yet Neglected Human Retrovirus: From Transmission to Therapeutic Treatment
by: Nicolas Futsch, et al.
Published: (2017-12-01)

Extracellular Vesicles in HTLV-1 Communication: The Story of an Invisible Messenger
by: Sarah Al Sharif, et al.
Published: (2020-12-01)

A newly identified interaction between nucleolar NPM1/B23 and the HTLV-I basic leucine zipper factor in HTLV-1 infected cells
by: Zhenlong Liu, et al.
Published: (2022-12-01)

HTLV-1 HBZ Protein Resides Exclusively in the Cytoplasm of Infected Cells in Asymptomatic Carriers and HAM/TSP Patients
by: Greta Forlani, et al.
Published: (2019-04-01)

New Perspectives about Drug Candidates Targeting HTLV-1 and Related Diseases
by: Milena Cristina Martins da Silva, et al.
Published: (2023-11-01)

Interplay between innate immunity and the viral oncoproteins Tax and HBZ in the pathogenesis and therapeutic response of HTLV-1 associated adult T cell leukemia
by: Hiba El Hajj, et al.
Published: (2022-07-01)

Cell Surface Markers in HTLV-1 Pathogenesis
by: Andrea K. Kress, et al.
Published: (2011-08-01)

The Emerging Role of miRNAs in HTLV-1 Infection and ATLL Pathogenesis
by: Ramona Moles, et al.
Published: (2015-07-01)

PRMT5 Is Upregulated in HTLV-1-Mediated T-Cell Transformation and Selective Inhibition Alters Viral Gene Expression and Infected Cell Survival
by: Amanda R. Panfil, et al.
Published: (2015-12-01)

Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma
by: Daniel A. Rauch, et al.
Published: (2020-08-01)

Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseases
by: Marcia Bellon, et al.
Published: (2021-06-01)

Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis
by: Satoshi Nozuma, et al.
Published: (2017-04-01)

Human T-cell Leukemia Virus Type 1 and <i>Strongyloides stercoralis</i>: Partners in Pathogenesis
by: Adam Dykie, et al.
Published: (2020-10-01)

Integration of gene co-expression analysis and multi-class SVM specifies the functional players involved in determining the fate of HTLV-1 infection toward the development of cancer (ATLL) or neurological disorder (HAM/TSP).
by: Mohadeseh Zarei Ghobadi, et al.
Published: (2022-01-01)

Differential modulation of IL-4, IL-10, IL-17, and IFN-γ production mediated by IgG from Human T-lymphotropic virus-1 (HTLV-1) infected patients on healthy peripheral T (CD4+, CD8+, and γδ) and B cells
by: Nicolle Rakanidis Machado, et al.
Published: (2023-08-01)

HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) versus adult T-cell leukemia/lymphoma (ATLL)
by: Mohadeseh Zarei-Ghobadi, et al.
Published: (2021-03-01)

p30 protein: a critical regulator of HTLV-1 viral latency and host immunity
by: Ramona Moles, et al.
Published: (2019-12-01)

Global expression of noncoding RNome reveals dysregulation of small RNAs in patients with HTLV-1–associated adult T-cell leukemia: a pilot study
by: Andrezza Nascimento, et al.
Published: (2021-01-01)